MedTrace Logo

Dexamethasone for Pain After Shoulder Surgery

NCT01414569 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2013-06-04

No results posted yet for this study

Summary

The purpose of this study is to determine if a dose of 40 mg dexamethasone is more effective as pain treatment than the currently used dose of 8 mg after arthroscopic shoulder surgery.

Conditions

Interventions

DRUG

Dexamethasone

Singe dose preoperatively in 100 ml saline intravenously

Sponsors & Collaborators

  • Horsens Hospital

    collaborator OTHER

  • Central Denmark Region

    collaborator OTHER

  • The Hede Nielsen Family Foundation

    collaborator OTHER

  • The Danish Rheumatism Association

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Karen T Bjørnholdt, MD · Aarhus University, Horsens Hospital

  • Kjeld Søballe, Prof. dr.med. · Aarhus University Hospital

  • Lone Nikolajsen, ph.d., MD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-04-30
Completion
2013-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01414569 on ClinicalTrials.gov